View Clinical Trial (Medical Research Study)
Xanthine Oxidase Inhibition in Renal Transplant Recipients
| City: |
|
Iowa City |
| State: |
|
Iowa |
| Zip Code: |
|
52240 |
| Conditions: |
|
Complications of Renal Transplant |
| Purpose: |
|
Cardiovascular disease is the leading cause of mortality in kidney transplantation. The
enzyme xanthine oxidase may play an important role in the cardiovascular disease of kidney
transplant recipients. Inhibiting this enzyme with allopurinol may improve vascular health
and protects against cardiovascular complications.
|
| Study Summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- age 18 years or older
- both genders
- recipients of living donor or deceased-donor kidney transplant with stable renal
function
Exclusion Criteria:
- history of gout
- allergy to allopurinol
- use of azathioprine
|
| NCT ID: |
|
NCT01332799 |
| Primary Contact: |
|
Principal Investigator
Roberto S Kalil, MD
University of Iowa
Roberto S Kalil, MD
Phone: 319 384-7998
Email: roberto-kalil@uiowa.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Iowa City, Iowa 52240
United States
There is no listed contact information for this specific location.
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|